Bobbyinvest great post and link to CYDY- UCLA - This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria because the FDA is short staffed within that capacity. We have all verbal and email approvals to utilize Leronlimab and start the trial treating COV19 patients.
From Dr. Yang:
However, Yang said to all shorting CYDY he believes there is strong evidence to support this theory that "Leronlimab" saved her life.
“In 24 hours, she started requiring less oxygen on the ventilators, and 48 hours after that, she was able to come off the ventilator all together,” Yang said. ‘Then a couple of days after that, she didn’t require any oxygen at all.”
How Chump read it!
News 
Market Data 
Discover 
